Biotech Daily reports daily news on the sector and rarely makes a comment. The following issues have been judged as of concern to the entire sector and we have added our voice. Editor David Langsam takes responsibility for the opinion, except for articles cosigned by analyst Marc Sinatra.



2021 - The Year In Review

Another Year In The Grass - With Shrooms & E

Editorial: Selective Briefings & ASX Listing Rule 15.7

Budget 2021 Special Edition; Comment & Response

2020 - The Year In Review

A Year In The Grass - Medical Marijuana Review

Budget 2020 Special Edition; Comment & Analysis

Biotech Daily 1st Medical Marijuana Survey

CSIRO, Doherty Distance From 'Tier 1' Sars-Cov-2 Claims

Editorial: Covid-19 Spruikers, Please Stop !

Editorial: Covid-19 Coronavirus Claims

Editorial: The 2019-nCoV Coronavirus (Covid-19)

2019 - The Year In Review

All The Dope On Medicine, Marijuana, Cannabis & Hemp

BNYM & Substantial Shareholder Notices

Federal Election 2019: Policies & Comment

Budget 2019 Comment & Analysis

Your R&D Tax Incentive Is Not Revenue

2018 - The Year In Review

Victoria Election 2018 - Biotech Daily Editorial

Budget 2018 & Comment

Editorial: Something Is Rotten In Optiscan

Editorial: Doing The Deal

2017 - The Year In Review
- CEO, Chairman, Kamikaze of the Year 

Senator Michaelia Cash Appointed Innovation Minister
- Biotech Daily Editorial Comment - Dec 20, 2017

Biotech Daily 12th Birthday Editorial

Biotech Daily Editorial: Selective Briefings - Oct 11, 2017

Budget 2017: 1st MRFF Funding, Steady As She Goes
- Biotech Daily Editorial Comment

Welcome To 2017

2016 - The Year In Review: Money, Malcolm & Medical Marijuana

Ausbiotech, Biotech Daily: 'Don't Cut The 45% R&D Tax Incentive' - Sep 13, 2016

Federal Election 2016: Promises, Evidence And Credibility - Jun 30, 2016

Biotech Daily Policy On Mega-Day-Traders

Budget 2016: Not Much For Biotech
- Details, Comment: Research Australia, Biotech Daily
  University of Melbourne - Mar 3, 4, 2016